- Home
- IBG vs XXII Comparison
IBG vs XXII Comparison
Compare IBG & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBG
- XXII
- Stock Information
- Founded
- IBG 2018
- XXII 1998
- Country
- IBG Australia
- XXII United States
- Employees
- IBG N/A
- XXII N/A
- Industry
- IBG Beverages (Production/Distribution)
- XXII Medicinal Chemicals and Botanical Products
- Sector
- IBG Consumer Staples
- XXII Health Care
- Exchange
- IBG Nasdaq
- XXII Nasdaq
- Market Cap
- IBG 6.0M
- XXII 7.0M
- IPO Year
- IBG 2024
- XXII N/A
- Fundamental
- Price
- IBG $0.55
- XXII $8.09
- Analyst Decision
- IBG Strong Buy
- XXII
- Analyst Count
- IBG 1
- XXII 0
- Target Price
- IBG N/A
- XXII N/A
- AVG Volume (30 Days)
- IBG 115.7K
- XXII 37.6K
- Earning Date
- IBG 07-11-2025
- XXII 08-12-2025
- Dividend Yield
- IBG N/A
- XXII N/A
- EPS Growth
- IBG N/A
- XXII N/A
- EPS
- IBG N/A
- XXII N/A
- Revenue
- IBG $2,931,243.00
- XXII $23,869,000.00
- Revenue This Year
- IBG N/A
- XXII $22.41
- Revenue Next Year
- IBG N/A
- XXII $76.35
- P/E Ratio
- IBG N/A
- XXII N/A
- Revenue Growth
- IBG N/A
- XXII N/A
- 52 Week Low
- IBG $0.44
- XXII $6.28
- 52 Week High
- IBG $3.35
- XXII $2,837.04
- Technical
- Relative Strength Index (RSI)
- IBG N/A
- XXII 24.50
- Support Level
- IBG N/A
- XXII $6.81
- Resistance Level
- IBG N/A
- XXII $9.50
- Average True Range (ATR)
- IBG 0.00
- XXII 1.70
- MACD
- IBG 0.00
- XXII -0.32
- Stochastic Oscillator
- IBG 0.00
- XXII 20.46
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.